How many insider trades does FilingIQ track for LGVN?

FilingIQ tracks 193 Form 4 insider transactions for LGVN (Longeveron Inc.), covering filings from Feb 11, 2021 onwards. 14 of those were filed in the last 90 days.

Are LGVN insiders net buyers or net sellers?

Across the full Form 4 history for LGVN, 25 transactions (13%) were open-market purchases and 17 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does LGVN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is LGVN in?

Longeveron Inc. (LGVN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $20.77M.

LGVN insider trading

NasdaqCM Healthcare

Longeveron Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

193

Last 90 days

Buys / sells

13% / 9%

Market cap

$20.77M

About Longeveron Inc.

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Company website: longeveron.com

LGVN insider activity at a glance

FilingIQ has scored 193 insider transactions for LGVN since Feb 11, 2021. The most recent filing in our index is dated May 1, 2026.

Across the full history, 25 open-market purchases and 17 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on LGVN insider trades is 53.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live LGVN trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for LGVN?: FilingIQ tracks 193 Form 4 insider transactions for LGVN (Longeveron Inc.), covering filings from Feb 11, 2021 onwards. 14 of those were filed in the last 90 days.
Are LGVN insiders net buyers or net sellers?: Across the full Form 4 history for LGVN, 25 transactions (13%) were open-market purchases and 17 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does LGVN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is LGVN in?: Longeveron Inc. (LGVN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $20.77M.

Methodology & sources

Every LGVN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.